AEON
AEON Biopharma, Inc.
0.71
100 x undefined
100 x 0.77
bid
ask
-
0.01
1.15%
100 @ 08:44 AM
0.72 +0.01 (1.00%)
| Ytd | -35.36% | |
| 1y | -10.79% |
0.70
day range
0.72
0.51
52 week range
1.45
| Open | 0.75 | Prev Close | 0.72 | Low | 0.70 | High | 0.72 | Mkt Cap | 18.70M |
| Vol | 12.17K | Avg Vol | 78.02K | EPS | -6.52 | P/E | N/A | Forward P/E | -0.84 |
| Beta | 0.40 | Short Ratio | 1.60 | Inst. Own | 33.14% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.81 | 200-d Avg | 0.95 | 1yr Est | 5.00 |
| Income Statement | |||
| Operating Expenses | 5.93M | ||
| Research and Development Expense | 2.03M | ||
| Selling, General and Administrative Expense | 3.90M | ||
| Operating Income | -5.93M | ||
| Net Income | -11.79M | ||
| Net Income Common Stock | -11.79M | ||
| Net Income Common Stock (USD) | -11.79M | ||
| Consolidated Income | -11.79M | ||
| Earnings per Basic Share | -0.29 | ||
| Earnings per Basic Share (USD) | -0.29 | ||
| Earnings per Diluted Share | -0.29 | ||
| Earning Before Interest & Taxes (EBIT) | -11.79M | ||
| Earning Before Interest & Taxes (USD) | -11.79M | ||
| Weighted Average Shares | 40.61M | ||
| Weighted Average Shares Diluted | 40.61M | ||
| Balance Sheet | |||
| Cash and Equivalents | 6.24M | ||
| Cash and Equivalents (USD) | 6.24M | ||
| Current Assets | 6.63M | ||
| Property, Plant & Equipment Net | 1.13M | ||
| Total Assets | 8.63M | ||
| Total Debt | 2.37M | ||
| Current Liabilities | 6.67M | ||
| Debt Non-Current | 2.37M | ||
| Total Liabilities | 25.38M | ||
| Accumulated Retained Earnings (Deficit) | -482.61M | ||
| Shareholders Equity | -16.75M | ||
| Shareholders Equity (USD) | -16.75M | ||
| Assets Non-Current | 2.01M | ||
| Total Debt (USD) | 2.37M | ||
| Liabilities Non-Current | 18.71M | ||
| Trade and Non-Trade Payables | 1.48M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 19.00K | ||
| Net Cash Flow from Financing | 5.87M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.24M | ||
| Issuance (Purchase) of Equity Shares | 5.87M | ||
| Net Cash Flow from Operations | -2.64M | ||
| Share Based Compensation | 1.93M | ||